Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Exchange Rate Effect: 2020-2025

Historic Exchange Rate Effect for Silence Therapeutics (SLN) over the last 6 years, with Sep 2025 value amounting to -$106,000.

  • Silence Therapeutics' Exchange Rate Effect fell 139.55% to -$106,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $556,000, marking a year-over-year increase of 1189.02%. This contributed to the annual value of $60,000 for FY2024, which is 91.99% down from last year.
  • Latest data reveals that Silence Therapeutics reported Exchange Rate Effect of -$106,000 as of Q3 2025, which was down 153.54% from $198,000 recorded in Q2 2025.
  • Silence Therapeutics' 5-year Exchange Rate Effect high stood at $5.7 million for Q3 2022, and its period low was -$718,490 during Q4 2021.
  • In the last 3 years, Silence Therapeutics' Exchange Rate Effect had a median value of -$35,000 in 2024 and averaged $41,945.
  • In the last 5 years, Silence Therapeutics' Exchange Rate Effect skyrocketed by 2,605.56% in 2022 and then tumbled by 324.90% in 2023.
  • Silence Therapeutics' Exchange Rate Effect (MRQ) stood at -$718,490 in 2021, then soared by 168.07% to $489,111 in 2022, then crashed by 142.88% to -$209,755 in 2023, then increased by 24.20% to -$159,000 in 2024, then surged by 33.33% to -$106,000 in 2025.
  • Its Exchange Rate Effect stands at -$106,000 for Q3 2025, versus $198,000 for Q2 2025 and $232,000 for Q1 2025.